OPKO HEALTH, INC. Logo

OPKO HEALTH, INC.

A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.

OPK | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
4400 BISCAYNE BLVD., 33137 MIAMI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company focused on developing and commercializing innovative healthcare solutions. The company operates through two primary segments. Its pharmaceutical division develops novel therapies, with key products including NGENLA™, a long-acting human growth hormone treatment, and RAYALDEE®. The research pipeline focuses on multispecific therapies for cancer and infectious diseases, supported by partnerships with major pharmaceutical organizations. The diagnostics division, through its subsidiary BioReference Laboratories, is one of the largest full-service clinical reference laboratories in the U.S., offering a comprehensive portfolio of testing services to physicians and patients. By integrating its therapeutic and diagnostic capabilities, OPKO aims to establish leading positions in large, growing healthcare markets and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OPKO HEALTH, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPKO HEALTH, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OPKO HEALTH, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Merck & Co., Inc. Logo
A global biopharma developing innovative medicines, vaccines, and animal health products.
United States of America MRK
Mereo BioPharma Group plc Logo
A clinical-stage biopharma developing and commercializing novel therapies for rare diseases.
United States of America MREO
Mersana Therapeutics, Inc. Logo
Developing innovative antibody-drug conjugates using proprietary platforms to treat cancer.
United States of America MRSN
Merus N.V. Logo
Develops multispecific antibody therapies that harness the immune system to fight cancer.
United States of America MRUS
MESOBLAST LTD Logo
Develops off-the-shelf cellular medicines for complex inflammatory and chronic diseases.
United States of America MESO
Metagenomi, Inc. Logo
Discovering novel gene editing tools from nature for curative genetic medicines.
United States of America MGX
MetaVia Inc. Logo
A clinical-stage biotech developing novel drugs for cardiometabolic diseases like obesity and MASH.
United States of America MTVA
Metsera, Inc. Logo
Develops potent, long-acting oral & injectable therapies for obesity & metabolic diseases.
United States of America MTSR
Mezzion Pharma Co., Ltd. Logo
Develops and out-licenses novel therapeutics like udenafil, with a focus on rare diseases.
South Korea 140410
MFC Co., Ltd. Logo
A GMP-certified CDMO/CMO developing and manufacturing APIs for the global pharma sector.
South Korea 432980

Talk to a Data Expert

Have a question? We'll get back to you promptly.